ArticleEuropean journal of nuclear medicine and molecular imaging2024

First-in-human administration of terbium-161-labelled somatostatin receptor subtype 2 antagonist ([

Julia Fricke et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.